|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Real estate assets: | ||||||||||||||||||||
| Operating properties, net of accumulated depreciation of $1,944,115 and $1,922,394 in 2026 and 2025, respectively | ||||||||||||||||||||
| Projects under development | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Total properties | ||||||||||||||||||||
| Real estate assets and other assets held for sale, net | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Investments in real estate debt, at fair value | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Deferred rents receivable | ||||||||||||||||||||
| Investments in unconsolidated joint ventures | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Deferred income | ||||||||||||||||||||
| Intangible liabilities, net | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Liabilities of real estate assets held for sale, net | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Stockholders' investment: | ||||||||||||||||||||
| Common stock, $1 par value per share, 300,000,000 shares authorized, 164,602,058 and 167,981,990 issued and outstanding in 2026 and 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock at cost, 2,536,583 shares in 2023 | ||||||||||||||||||||
| Distributions in excess of cumulative net income | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders' investment | ||||||||||||||||||||
| Nonredeemable noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
| Common stock, shares outstanding (in shares) | ||||||||||||||||||||
Loading...
